News
Arkansas Attorney General Tim Griffin announced that the state has received $44.5 million as part of a Purdue Pharma settlement.
Purdue Pharma, a Stamford-based drug maker that has faced billions in fines for misleading the public on its addictive opioid OxyContin, has received court approval to pay more than $7.4 […] ...
By Natalie Weger Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors ...
Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...
A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids. State governments across the country have already signed on to ...
A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids.
Purdue Pharma’s $7B opioid settlement plan could get votes from victims and cities Members of the Sackler family who own the company would pay up to $7 billion and give up ownership on the company.
About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.
OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it ...
Purdue Pharma's $7B opioid settlement is set for votes from victims and cities A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the ...
Attorney General Liz Murrill says Louisiana will receive nearly $70 million over 15 years from Purdue Pharma’s $7.4 billion opioid settlement.
Purdue Pharma’s $7 billion opioid settlement could advance after states back it The deal calls for members of the Sackler family who own the company to give up ownership and to contribute up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results